Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Plas

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Blood Science (Baltimore, Md.)|April 11, 2022
Choreography of methylation: KDM4C histone demethylation enables ALKBH5 m6A RNA demethylation to sustain AML stem cellsPranjal Sarma, David R Plas
Current Opinion in Cell Biology|February 25, 2009
Tubers and tumors: rapamycin therapy for benign and malignant tumorsDavid R Plas, George Thomas
Cancer Biology & Therapy|July 28, 2009
Targeting bioenergetics to enhance cancer chemotherapy: mitochondria SLP into apoptosisShikha Khatri, David R Plas
Trends in Endocrinology and Metabolism: TEM|February 21, 2002
Cell metabolism in the regulation of programmed cell deathDavid R Plas, Craig B Thompson
Endocrine-Related Cancer|August 12, 2010
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesisJennifer F Barger, David R Plas
The Journal of Biological Chemistry|January 9, 2003
Akt activation promotes degradation of tuberin and FOXO3a via the proteasomeDavid R Plas, Craig B Thompson
Oncogene|November 17, 2005
Akt-dependent transformation: there is more to growth than just survivingDavid R Plas, Craig B Thompson
Nature Immunology|May 29, 2002
Homeostatic control of lymphocyte survival: potential origins and implicationsDavid R Plas, Jeffrey C Rathmell, Craig B Thompson
Autophagy|June 1, 2012
Not all autophagy is equalMaria F Czyzyk-Krzeska, Jarek Meller, David R Plas
Cancer Research|October 12, 2011
IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1Thomas G Sommermann, Kathleen O'Neill, David R Plas, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Blood Science (Baltimore, Md.)|April 11, 2022
Choreography of methylation: KDM4C histone demethylation enables ALKBH5 m6A RNA demethylation to sustain AML stem cellsPranjal Sarma, David R Plas
Current Opinion in Cell Biology|February 25, 2009
Tubers and tumors: rapamycin therapy for benign and malignant tumorsDavid R Plas, George Thomas
Cancer Biology & Therapy|July 28, 2009
Targeting bioenergetics to enhance cancer chemotherapy: mitochondria SLP into apoptosisShikha Khatri, David R Plas
Trends in Endocrinology and Metabolism: TEM|February 21, 2002
Cell metabolism in the regulation of programmed cell deathDavid R Plas, Craig B Thompson
Endocrine-Related Cancer|August 12, 2010
Balancing biosynthesis and bioenergetics: metabolic programs in oncogenesisJennifer F Barger, David R Plas
The Journal of Biological Chemistry|January 9, 2003
Akt activation promotes degradation of tuberin and FOXO3a via the proteasomeDavid R Plas, Craig B Thompson
Oncogene|November 17, 2005
Akt-dependent transformation: there is more to growth than just survivingDavid R Plas, Craig B Thompson
Nature Immunology|May 29, 2002
Homeostatic control of lymphocyte survival: potential origins and implicationsDavid R Plas, Jeffrey C Rathmell, Craig B Thompson
Autophagy|June 1, 2012
Not all autophagy is equalMaria F Czyzyk-Krzeska, Jarek Meller, David R Plas
Cancer Research|October 12, 2011
IKKβ and NF-κB transcription govern lymphoma cell survival through AKT-induced plasma membrane trafficking of GLUT1Thomas G Sommermann, Kathleen O'Neill, David R Plas, et al.
Pageof 7